However, whether CD247 is involved in the pathogenesis of IPF and becomes a potential therapeutic target of IPF, we need to carry out relevant basic experiments and prospective clinical trials to verify. This evidence concerns the gene CD247 and idiopathic pulmonary fibrosis.